In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Abbott Laboratories trades at a 20.8% discount to its weighted fair value of $134.35, indicating potential undervaluation. Strong financial health scores (4.00/5) and high-confidence DCF and analyst valuations support this. However, Monte Carlo analysis shows high volatility (CV 124.13%) and 47.1% downside risk below the current price.